Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
IgG4-Related Disease
and you are
The phase for this study is not defined.
Show me locations

The purpose

The aim of this study is to establish a nation-wide cohort study of IgG4-related disease (IgG4-RD) in China. Methods: All the patients fulfilling diagnostic criteria of IgG4-RD (2011) would be enrolled from multi-centers around China. A online database system has been established. Endpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IgG4-RD patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03023371. The sponsor of the trial is Peking Union Medical College Hospital and it is looking for 900 volunteers for the current phase.
Official trial title:
National Registry of IgG4-RD in China